Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -7.90
- Piotroski Score 2.00
- Grade Neutral
- Symbol (ANGN)
- Company Angion Biomedica Corp.
- Price $1.00
- Changes Percentage (0%)
- Change -$0
- Day Low $1.00
- Day High $1.00
- Year High $20.40
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/14/2023
- Fiscal Year End N/A
- Average Stock Price Target $15.00
- High Stock Price Target $15.00
- Low Stock Price Target $15.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$10.11
- Trailing P/E Ratio -0.09891196834817
- Forward P/E Ratio -0.09891196834817
- P/E Growth -0.09891196834817
- Net Income $-55,700,000
Income Statement
Quarterly
Annual
Latest News of ANGN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Ralf Rangnick's club ethos gives Austria belief they can go all the way | Nick Ames
The confidence and unity cultivated by Red Bull's influence are propelling Austria to unexpected success in Euro 2024. Led by Ralf Rangnick, the team's familiarity with Leipzig's model is proving adva...
By The Guardian | 4 months ago
